SEC Form 4 · purchase transaction · filed Sep 30, 2026
Plott Ronald Todd purchased $5.2K of Phio Pharmaceuticals Corp.
Plott Ronald Todd (Director) disclosed a purchase of 5,000 shares of Phio Pharmaceuticals Corp. (PHIO) at $1.04 per share on Sep 29, 2026, in a Form 4 filed with the SEC on Sep 30, 2026. Disclosed value $5.2K. 2 distinct insiders disclosed purchases of Phio Pharmaceuticals Corp. in the 7 days to Sep 30, 2026, within Flock's Form 4 coverage.
The filing, as filed
| Reporting insider | Plott Ronald Todd |
|---|---|
| Role as filed | Director |
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Security as filed | Common Stock, $.0001 par value |
| Transaction | Purchase (Form 4 transaction code P: open-market or private purchase) |
| Shares | 5,000 |
| Price per share | $1.04 |
| Disclosed value | $5,200.00 ($5.2K; quantity × the filing's stated price) |
| Trade date | Sep 29, 2026 |
| Filed with the SEC | Sep 30, 2026 |
Source: SEC EDGAR Form 4. Purchase transactions only (code P) — grants, option exercises and tax withholdings are different facts and are never shown as buys. Superseded filings are excluded. Coverage: the US issuers in Flock's Form 4 scope (securities mapped from institutional 13F holdings), not every SEC registrant.
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.